Tumor Ablation Market Growth, Outlook and Specifications Forecast to 2022

Global Tumor Ablation Market is anticipated to grow at a higher CAGR in the forthcoming period. A tumor ablation device comprises an ablation instrument and a generator with a 5W and 10W setting. The device also has a flexible tip containing a bipolar electrode and a heat sensor. Clinically, ablation procedure is performed under fluoroscopic or computed tomography with the patient lying face down.

The electrode tube, also called as introducer is put through a small hole in the skin and correctly aligned at the tumor site. Radiofrequency is then conveyed via electrode to heat and eliminate the tumor. Heat sensors monitors the temperature at the edge of ablation zone in real time, enabling the physician to regulate energy level being put and also to lessen the destruction to the adjacent healthy tissue.


Driving factors responsible for the growth of Tumor Ablation Market includes availability of clinical significance and rise in safety framework, growth in funding to enhance research activities under public-private initiatives that further offers tremendous opportunities. Also, other factors such as rise in awareness of ablation procedure compared to other minimal invasive procedures. Additionally, favorable opportunities in healthcare market contributes to the growth of the market. However, fatal injury at a cellular level and architectural deconstruction at a tissue level is likely to affect the growth of Tumor Ablation Industry.

Based on technological segmentation, the Tumor Ablation Market includes microwave ablation, radiofrequency ablation, cryoablation, high-intensity focused ultrasound and laser interstitial thermal ablation. Based on segmentation by treatment, the Tumor Ablation Industry includes surgical ablation, percutaneous ablation and laparoscopic ablation. Based on segmentation by application, the Tumor Ablation Industry includes lung cancer, liver cancer, bone metastasis and kidney cancer.

Geographically, Tumor Ablation Market includes North America, Latin America, Europe, Asia-Pacific, Middle-East and Africa. APAC market is expected to gain a positive CAGR growth in the forthcoming period. India and China being the prominent players in APAC market owing to lucrative growth and rising prevalence of cancer along with inclination of patients towards minimally invasive therapies. North America is anticipated to grow at a higher CAGR in the forthcoming period due to the rise in R&D expenditure by government and healthcare sector.

The key players in the Tumor Ablation Market include Boston Scientific, Medtronic, Galil Medical, EDAP, TMS, Angiodynamics, Mermaid, INITIO Inc, Mermaid Medical Inc, Sonacare Medical, Neuwave Medical and Mesonix.

No comments:

Post a Comment

Fish Oil Industry Shares, Opportunities, Trends and Market Restraints Analysis by 2022

10 July 2019: The global Fish Oil Market size is expected to value at USD 4.08 billion by 2022. The market is subject to witness a subst...